Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial

doi:10.2196/resprot.9374

JMIR Research Protocols

Browse by Year:

Browse:
Issues
Authors
Themes

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, December 24 through Wednesday, December 26 inclusive. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Monday, December 24.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Monday, December 24.

JMIR Research Protocols

Citation

Please cite as:

Loading authors...

Export Metadata

Download:

Published on 09.04.18 in Vol 7, No 4 (2018): April

This paper is in the following e-collection/theme issue:

Works citing "Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial"

Ra'eesa Doola, Alwyn S Todd, Josephine M Forbes, Adam M Deane, Jeffrey J Presneill, David J Sturgess

JMIR Res Protoc 2018 (Apr 09); 7(4):e90

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.9374):

(note that this is only a small subset of citations)

No citing articles found.

JMIR Research Protocols

Citing this Article

Published on 09.04.18 in Vol 7, No 4 (2018): April

This paper is in the following e-collection/theme issue:

Works citing "Diabetes-Specific Formulae Versus Standard Formulae as Enteral Nutrition to Treat Hyperglycemia in Critically Ill Patients: Protocol for a Randomized Controlled Feasibility Trial"